Assessment of small intestinal bacterial overgrowth and methane production in patients on chronic proton-pump inhibitor treatment: prevalence and role of rifaximin in its management in primary care.
DE Bastiani R, Lopetuso LR, DE Bastiani M, Bacchin P, Benedetto E, Boscariolo L, Caneve R, Chesani F, Chiumeo F, Civic Z, Dainese A, DE Polo M, Disclafani G, Grattagliano I, Mana O, Mancuso M, Mastronuzzi T, Pati A, Pirrotta E, Salandini M, Sanna G, Scoglio R, Severino P, Tosetti C, Turnava L, Zamparella M, Elisei W, Gasbarrini A, Tursi A.
DE Bastiani R, et al. Among authors: scoglio r.
Minerva Gastroenterol (Torino). 2023 Dec;69(4):523-528. doi: 10.23736/S2724-5985.21.03118-1. Epub 2023 Mar 21.
Minerva Gastroenterol (Torino). 2023.
PMID: 36943203